Efficacy of a Second Tumor Necrosis Factor Inhibitor (TNFi) in the Treatment of Rheumatoid Arthritis (RA)

被引：0
|
作者：
Reams, Jennifer [1 ]
Berger, Andrea [2 ]
Dunn, Philip [2 ]
O'Connell, Eva [3 ]
Torelli, William [2 ]
Bankert, Jason [2 ]
Bashir, Muhammed [2 ]
Denio, Alfred [1 ]
机构：
[1] Geisinger Med Ctr, Rheumatol, Danville, PA 17822 USA
[2] Geisinger Med Ctr, Danville, PA 17822 USA
[3] Geisinger Med Ctr, Internal Med, Danville, PA 17822 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
620
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy predictors of a second tumor necrosis factor inhibitor in the treatment of rheumatoid arthritis
    Reams, Jennifer
    Berger, Andrea
    Denio, Alfred
    [J]. MEDICINE, 2020, 99 (35)
  • [2] Effectiveness of Monotherapy in Rheumatoid Arthritis (RA) Patients Initiating a Tumor Necrosis Factor Inhibitor (TNFi) Vs a Non-TNFi in a Large US Commercial and Medicare Advantage Plan
    Chastek, Benjamin
    Curtis, Jeffrey R.
    Becker, Laura K.
    Joseph, George J.
    Chen, Chieh-I
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [3] Golimumab: A Tumor Necrosis Factor Alpha Inhibitor for the Treatment of Rheumatoid Arthritis
    McCluggage, Lauren K.
    Scholtz, Jean M.
    [J]. ANNALS OF PHARMACOTHERAPY, 2010, 44 (01) : 135 - 144
  • [4] Efficacy and security of tumor necrosis factor antagonists in the treatment of rheumatoid arthritis
    Perez Pampin, Eva
    Carnota, Juan Jesus Gomez-Reino
    [J]. MEDICINA CLINICA, 2008, 130 (05): : 179 - 187
  • [5] Tumor necrosis factor inhibitor therapy for rheumatoid arthritis
    Naguwa, SM
    [J]. AUTOIMMUNE DISEASES AND TREATMENT: ORGAN-SPECIFIC AND SYSTEMIC DISORDERS, 2005, 1051 : 709 - 715
  • [6] Discontinuation of TNFi Treatment Among Rheumatoid Arthritis Patients with a Molecular Signature of Non-response to Tumor Necrosis Factor-α Inhibitor Therapies
    Curtis, Jeffrey
    Kremer, Joel
    Pappas, Dimitrios
    Zhang, Lixia
    Connolly-Strong, Erin
    Withers, Johanna
    Akmae, Viatcheslav
    Saleh, Alif
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2589 - 2590
  • [7] Tocilizumab and rituximab have similar effectiveness and are both superior to a second tumour necrosis factor inhibitor (TNFi) in rheumatoid arthritis patients who discontinued a first TNFi
    Santos-Faria, D.
    Tavares-Costa, J.
    Eusebio, M.
    Leite Silva, J.
    Ramos Rodrigues, J.
    Sousa-Neves, J.
    Duarte, A. C.
    Lopes, C.
    Valido, A.
    Dinis, J.
    Freitas, J.
    Santiago, M.
    Ferreira, R.
    Ganhao, S.
    Miranda, L.
    Peixoto, D.
    Teixeira, F.
    Alcino, S.
    Afonso, C.
    Santos, M. J.
    [J]. ACTA REUMATOLOGICA PORTUGUESA, 2019, 44 (02): : 103 - 113
  • [8] Tumor necrosis factor (TNF) inhibitor therapy for rheumatoid arthritis
    Segal, Barbara
    Rhodus, Nelson L.
    Patel, Ketan
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2008, 106 (06): : 778 - 787
  • [9] Secondary syphilis following tumor necrosis factor-α inhibitor treatment for rheumatoid arthritis
    Asahina, Akihiko
    Ishii, Norihisa
    Tohma, Shigeto
    [J]. JOURNAL OF DERMATOLOGY, 2012, 39 (02): : 199 - 201
  • [10] COMPARISON OF PATIENTS (PTS) WITH RHEUMATOID ARTHRITIS (RA) AMONG DISEASE ACTIVITY CATEGORIES AFTER 6 MONTHS OF TREATMENT WITH A TUMOUR NECROSIS FACTOR INHIBITOR (TNFI): RESULTS FROM THE CORRONA® RA REGISTRY
    Kremer, J. M.
    Winkler, A.
    Anatale-Tardiff, L.
    Mclean, R.
    Shan, Y.
    Moore, P.
    Tundia, N.
    Suboticki, J.
    Tesser, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 625 - 625
12345